Crossmark

Pharmacodynamic target attainment of the synergism of ceftazidime-avibactam in combination with amikacin against OXA-producing extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa

Crossref DOI link: https://doi.org/10.1007/s10096-025-05090-z

Published Online: 2025-03-08

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kang, Yixin

Cui, Junchang
License Information

Text and Data Mining valid from 2025-03-08

Version of Record valid from 2025-03-08
More Information

Article History

Received: 26 August 2024

Accepted: 25 February 2025

First Online: 8 March 2025

Declarations

:

: This work did not involve ethical issues. The study does not involve patients’ privacy. No ethical approval was required.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below